Lapatinib potentiates cytotoxicity of  YM155 in neuroblastoma via inhibition of the ABCB1 efflux transporter

Adverse side effects of cancer agents are of great concern in the context of childhood tumors where they can reduce the quality of life in young patients and cause life-long adverse effects. Synergistic drug combinations can lessen potential toxic side effects through lower dosing and simultaneously...

Descripción completa

Detalles Bibliográficos
Autores principales: Radic-Sarikas, Branka, Halasz, Melinda, Huber, Kilian V. M., Winter, Georg E., Tsafou, Kalliopi P., Papamarkou, Theodore, Brunak, Søren, Kolch, Walter, Superti-Furga, Giulio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5465103/
https://www.ncbi.nlm.nih.gov/pubmed/28596528
http://dx.doi.org/10.1038/s41598-017-03129-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5465103/
https://www.ncbi.nlm.nih.gov/pubmed/28596528
http://dx.doi.org/10.1038/s41598-017-03129-6

Ejemplares similares